Company News

Beckman Coulter Diagnostics and COPAN Announce Expansion of Distribution Agreement for Automated Sample Processing Systems and Digital Microbiology

August 10, 2014

Beckman Coulter Diagnostics, a global leader in clinical diagnostics, and COPAN, a company committed to innovation in the field of pre-analytics, today announced that Beckman Coulter Diagnostics and COPAN Group have entered into an amendment to their distribution agreement that expands their relationship into new products and geographic territories. Additional products include COPAN’s WASPLab automated, front-end robotic specimen processing, full lab automation and digital microbiology system. The amendment grants Beckman Coulter distribution rights in 21 global markets, including a number of territories in North America, Asia (including, among other territories, Japan and China), Europe, South America and many emerging markets.

We’re very excited to expand our relationship with COPAN to offer clinical microbiology laboratories an extended portfolio of products to help provide physicians with the critical information they need regarding bacteria resistance,” said Arnd Kaldowski, president, Beckman Coulter Diagnostics. “COPAN’sproductscomplementournewlyacquiredMicroScan brand of microbiology solutions and offer hospitals and private laboratories a complete solution which streamlines workflow—demonstrating Beckman Coulter’s commitment to growth and is invested in this new area of our business.”

Stefania Triva, COPAN Group’s CEO said, “Thisisanewstepinthecollaborationbetweenthe two companies and we look forward to continue working together to expand our reach.” Norman Sharples, Executive VP and Co-Founder of COPAN Diagnostics, Inc. added, “COPAN has always been committed to provide open platform solutions to our customers and this partnership is further evidence and reinforcement of our ability to integrate and interface with important platforms in microbiology.”

In addition to WASPLab, the amendment allows Beckman Coulter to distribute COPAN’s C- Tracer, SYNAPSEPro MINI and MALDI-Trace products.

About Beckman Coulter

Beckman Coulter Diagnostics develops clinical diagnostic products that help advance and optimize the clinical laboratory. Beckman Coulter’s instruments, systems and tests help streamline processes to enhance efficiency, reduce costs and speed the delivery of results. For 80 years, Beckman Coulter has been a global leader devoted to providing solutions to laboratories of all sizes, offering a broad portfolio of chemistry, immunoassay, hematology, urinalysis, microbiology, automation and information systems. Beckman Coulter is dedicated to advancing healthcare for every person and moving science, innovation and the lab forward. For more information, visit

About COPAN Group

With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN’s collaborative approach to pre-analytics has laboratory automation solutions, WASP and WASPLab. For more information, visit

Beckman Coulter, the stylized logo and Micro Scan are trademarks of Beckman Coulter, Inc. and registered in the USPTO.

WASP, WASPLab, C-Tracer, MALDI-Trace, SYNAPSE ProMINI, FLOQSwabs, ESwabandUTMareregistered trademarks or trademarks of Copan ItaliaSpA.